Cempra has two antibiotic candidates, solithromycin (CEM-101) and TAKSTA™ (CEM-102, sodium fusidate), in clinical trials. Both target the growing problem of antimicrobial resistance.
Solithromycin is a next-generation macrolide, the first fluorok...查看全文
$Cempra(CEMP)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-01-05 AccNo: 0001193125-16-421382 Size: 652 KB 网页链接
$Cempra(CEMP)$ 8-K - Current report Filed: 2015-12-23 AccNo: 0001193125-15-411768 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cempra(CEMP)$ 内部交易: 2015-12-11,Chief Medical Officer,Oldach David W. ,卖出,8222普通股, $30.33
$Cempra(CEMP)$ 内部交易: 2015-12-15,Chief Medical Officer,Oldach David W. ,卖出,1778普通股, $30.00
$Cempra(CEMP)$ 内部交易: 2015-12-15,Chief Medical Officer,Oldach David W. ,期权,1778普通股, $2.28
$Cempra(CEMP)$ 内部交易: 2015-12-11,Chief Medical Officer,Oldach David W. ,期权,8222普通股, $2.28
$Cempra(CEMP)$ 8-K - Current report Filed: 2015-11-17 AccNo: 0001193125-15-379153 Size: 21 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cempra(CEMP)$ 美东时间 2015-11-19 11:40 Cempra Inc at Jefferies Global Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2015-11-19 11:40 Cempra Inc at Jefferies Global Healthcare Conference 网页链接
$Cempra(CEMP)$ 美东时间 2015-11-17 10:15 Cempra Inc at Stifel Healthcare Conference 网页链接